Delivery Order SPE2DB24D2010-SPE2DB25FZZE4
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,402.20. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through open competition. The order is scheduled for ultimate completion by June 20, 2025, and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $10,374.00 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets (300 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,099.86 to AmerisourceBergen Drug Corp for the supply of Doxycycline 50 mg tablets (60-count packages) with an ultimate completion date of July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,456.56 to AmerisourceBergen Drug Corp for the supply of Doxycycline Monohydrate 100 mg tablets (250 count) with a completion date of July 30, 2025. This competitive award utilizes firm fixed-price pricing and involves no set-aside designation. The place of performance is AmerisourceBergen Drug Corp's location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,369.59 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets (500 count) under a firm fixed price contract type. The award, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive set-aside delivery order fulfilled from the vendor's existing contract vehicle. Performance will be completed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, valued at $2,151.96. This is a firm fixed price delivery order with an ultimate completion date of June 9, 2025, and represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $36,926.06 to AmerisourceBergen Drug Corp for the supply of Doxycycline Mono 100 mg tablets in quantities of 250 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 10, 2025. The award was made on November 7, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Doxycycline is a broad-spectrum antibiotic commonly used...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 9, 2025, for the supply of Doxycycline Hydrochloride 200 mg tablets in a 60-count package. This firm fixed-price delivery order, valued at $9,367.44, is scheduled for completion by July 10, 2025, and represents a non-set-aside competitive award. The product will be supplied from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $2,576.30 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Doxycycline Mono 100 mg tablets in quantities of 250 units. This is a firm fixed-price, non-set-aside contract with a completion date of July 15, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Doxycycline is a broad-spectrum tetracycline antibiotic commonly used by military and federal healthcare systems for treating...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a ceiling value of $3,597.84. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FZZE4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,413.11 to AmerisourceBergen Drug Corp for the supply of Doxycycline Mono 100 mg tablets (250-count unit) on May 30, 2025, with an ultimate completion date of June 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier within the federal medical supply chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 potential value through December 2026. This prime contract vehicle supports comprehensive global pharmaceutical supply requirements for military healthcare programs and serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The current doxycycline award exemplifies the routine pharmaceutical fulfillment occurring under this expansive IDC, which encompasses a diverse portfolio of generic and brand-name medications, vaccines, and medical supplies across multiple therapeutic categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 5/30/25 |